KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Cash & Equivalents (2016 - 2026)

Xylem has reported Cash & Equivalents over the past 17 years, most recently at $808.0 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 23.7% year-over-year to $808.0 million; the TTM value through Mar 2026 reached $808.0 million, down 23.7%, while the annual FY2025 figure was $1.5 billion, 31.94% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $808.0 million at Xylem, down from $1.5 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.5 billion in Q4 2025 and troughed at $705.0 million in Q3 2023.
  • A 5-year average of $1.0 billion and a median of $1.0 billion in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: plummeted 40.56% in 2023 and later skyrocketed 43.56% in 2025.
  • Year by year, Cash & Equivalents stood at $944.0 million in 2022, then increased by 7.94% to $1.0 billion in 2023, then grew by 10.01% to $1.1 billion in 2024, then skyrocketed by 31.94% to $1.5 billion in 2025, then plummeted by 45.37% to $808.0 million in 2026.
  • Business Quant data shows Cash & Equivalents for XYL at $808.0 million in Q1 2026, $1.5 billion in Q4 2025, and $1.2 billion in Q3 2025.